MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0046259
Avlaan Pharmaceutical Private Limited - chemicals and materials in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹19.36 Cr
▲ 28% YoY
Net profit · FY 2024
₹53.35 Lakh
Net margin 2.8%
EBITDA · FY 2024
₹76.11 Lakh
EBITDA margin 3.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
12 yrs
Est. 2014
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Avlaan Pharmaceutical Private Limited
Data last updated:
Avlaan Pharmaceutical Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 04 December 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24100TN2014PTC098319. Its GSTIN is 33AANCA0494Q1Z5 (Tamil Nadu).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Anurag Lodha and Arun Natarajan.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹19.36 Cr, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹53.35 Lakh (net margin 2.8%) and EBITDA of ₹76.11 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 9% over five years.
The company is associated with 1 brand: Avlaan.
Avlaan Pharmaceutical Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0046259). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website avlaanpharma.com.
Company details
CIN U24100TN2014PTC098319
Registration Number 098319
Incorporation Date 04 December 2014
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TN-02-0046259
Recognitions & Rankings of Avlaan Pharmaceutical
Contact details
Avlaan Pharmaceutical Private Limited's registered office is in Chennai, Tamil Nadu. Its website is avlaanpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSree Krishna Leela Unit 3 1st Floor, New No.34 2nd Main Road, Chennai, Tamil Nadu, India – 600028
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Avlaan Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Avlaan Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Avlaan Pharmaceutical operates one associated brand: Avlaan. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers specialty plant-based ingredients for vegan food and nutraceutical applications worldwide. | avlaanpharma.com |
Business activity
The main business activity of Avlaan Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Avlaan Pharmaceutical Private Limited, buy the company report.
Financials of Avlaan Pharmaceutical Private Limited
FY 2025 filings availableAvlaan Pharmaceutical Private Limited reported revenue of ₹19.36 Cr (up 28% YoY) for FY 2024.
Revenue · FY 2024
₹19.36 Cr ▲ 28%
Net profit · FY 2024
₹53.35 Lakh margin 2.8%
EBITDA · FY 2024
₹76.11 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 28%
3 years · compounded
▼ 9%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▼ 52%
3 years · compounded
▼ 9%
5 years · compounded
▼ 7%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 28% growth in the latest year. EBITDA fell 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹76.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹53.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | ||||
| Net Profit Margin | 2.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Avlaan Pharmaceutical Private Limited, buy the company report.
Board of directors of Avlaan Pharmaceutical Private Limited
Avlaan Pharmaceutical has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anurag Lodha | Director | 04 Dec 2014 | 11 Years 10 Months | Current |
| Arun Natarajan | Director | 04 Dec 2014 | 11 Years 10 Months | Current |
| Sethuraman Raju | Director | 23 Apr 2025 | 1 Years 6 Months | Current |
Peer comparison
Avlaan Pharmaceutical Private Limited is compared with the 3 companies closest to it by revenue in the Chemicals industry (Formulations, Specialty Chemicals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Paramount Builtech Private Limited | ₹19.43 Cr (FY 2024) | 3.0% | Delhi, India | |||
| Avlaan Pharmaceutical Private Limitedthis company | ₹19.36 Cr (FY 2024) | ₹53.35 Lakh | 2.8% | 28.0% | Chennai, Tamil Nadu, India | |
| Medic Biologicals and Pharmaceuticals Private Limited | ₹19.33 Cr (FY 2025) | 26.0% | Thiruvananthapuram, Kerala, India | |||
| Lxir Medilabs Private Limited | ₹19.32 Cr (FY 2025) | 20.0% | Panchkula, Haryana, India |
To see the full peer comparison of Avlaan Pharmaceutical Private Limited, buy the company report.
Auditor
Avlaan Pharmaceutical Private Limited is audited by K MUNUSAMI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K MUNUSAMI & CO | FY 2023 | 005602S |
Shareholding
The shareholding of Avlaan Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Avlaan Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Avlaan Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avlaan Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Avlaan Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AANCA0494Q1Z5 | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Avlaan Pharmaceutical Private Limited, buy the company report.
Recent activity
Avlaan Pharmaceutical Private Limited has 3 board changes on record since 2014: 3 appointments. The latest: Sethuraman Raju was appointed as Director on 23 Apr 2025.
AGM
Avlaan Pharmaceutical Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Appointed
Sethuraman Raju was appointed as Director.
Filing
Avlaan Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Anurag Lodha was appointed as Director.
Appointed
Arun Natarajan was appointed as Director.
Incorporation
04 Dec 2014
Avlaan Pharmaceutical Private Limited was registered on 04 Dec 2014 with Roc Chennai & aged 11 years 10 months as per MCA records.
Frequently asked questions
Avlaan Pharmaceutical is an active private limited company based in Chennai, Tamil Nadu, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 04 December 2014 (12+ years old) and is registered under CIN U24100TN2014PTC098319.
Avlaan Pharmaceutical has 3 current directors:
- Anurag Lodha - Director
- Arun Natarajan - Director
- Sethuraman Raju - Director
The latest financial statements of Avlaan Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Avlaan Pharmaceutical is 33AANCA0494Q1Z5, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Avlaan Pharmaceutical is U24100TN2014PTC098319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avlaan Pharmaceutical was incorporated on 04 December 2014, making it 12+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Avlaan Pharmaceutical by revenue are Paramount Builtech Private Limited, Medic Biologicals and Pharmaceuticals Private Limited, Lxir Medilabs Private Limited, all in the Chemicals industry (Formulations, Specialty Chemicals), with the same principal business activity (wholesale trading).
Sethuraman Raju was appointed as Director on 23 Apr 2025. Anurag Lodha was appointed as Director on 04 Dec 2014. Arun Natarajan was appointed as Director on 04 Dec 2014.
Yes, Avlaan Pharmaceutical is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0046259).
Avlaan Pharmaceutical can be reached through the website avlaanpharma.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Avlaan Pharmaceutical is at Sree Krishna Leela Unit 3 1st Floor, New No.34 2nd Main Road, Chennai, Tamil Nadu, India – 600028.